HUYGENSTM catheter market
The estimated addressable markets for Neuro-Kinesis’ Huygens™ Catheter and associated products are significant and represent sizable opportunities for growth. In the field of Electrophysiology alone, the current addressable market is estimated to be approximately $3.9 billion. For the application of Renal Denervation, catheters for the treatment of hypertension are estimated by industry analysts to make up a growing market opportunity that will represent $2.5 billion in 2020. Comparable growth is expected in the market for implantable Cardioverter-Defibrillators and their associated catheter leads. Analysts expect that with over 500,000 implants being done annually around the globe today, this sector comprises more than $7.8 billion of the disposable catheter market. Neuro-Kinesis is perfectly positioned to capture the expanding market for electrode-tipped disposable catheters. By offering a level of accuracy, affordability, and ease of use, there is no other product technology currently on the market that can compete with it.
- The EP Catheter market five-year forecast shows a continuing compound annual growth rate (CAGR) of 12.5%.
- Market share by region is lead by North America, followed by Europe, the Asia Pacific, and Latin America with the Asia-Pacific market showing the fastest growing CAGR of 15.3%.
- Growth is expected in all EP Catyheter categories including Diagnostic EP Catheters, Advanced EP Diagnostic Catheters, Ultrasound EP Diagnostic Catheters, and all Ablation EP Catheter (RF EP Ablation Catheters, Cryoablation EP Catheters, Laser Ablation Systems, and Microwave Ablation).
- The key market players in the EP Catheter market include Medtronic Plc, Boston Scientific Corporation, CardioFocus Inc, Hansen Medical, Inc., Lepu Medical Tech Co. Ltd, MicroPort Scientific Corporation, BIOTRONIK SE and Co. KG, Abbott Laboratories Inc., and Johnson and Johnson.